全文获取类型
收费全文 | 10377篇 |
免费 | 1131篇 |
国内免费 | 695篇 |
专业分类
耳鼻咽喉 | 113篇 |
儿科学 | 270篇 |
妇产科学 | 17篇 |
基础医学 | 392篇 |
口腔科学 | 9篇 |
临床医学 | 1028篇 |
内科学 | 2072篇 |
皮肤病学 | 8篇 |
神经病学 | 15篇 |
特种医学 | 461篇 |
外科学 | 1764篇 |
综合类 | 1640篇 |
预防医学 | 506篇 |
药学 | 760篇 |
6篇 | |
中国医学 | 91篇 |
肿瘤学 | 3051篇 |
出版年
2024年 | 18篇 |
2023年 | 121篇 |
2022年 | 326篇 |
2021年 | 397篇 |
2020年 | 317篇 |
2019年 | 273篇 |
2018年 | 292篇 |
2017年 | 278篇 |
2016年 | 341篇 |
2015年 | 453篇 |
2014年 | 823篇 |
2013年 | 676篇 |
2012年 | 777篇 |
2011年 | 846篇 |
2010年 | 695篇 |
2009年 | 651篇 |
2008年 | 605篇 |
2007年 | 599篇 |
2006年 | 574篇 |
2005年 | 497篇 |
2004年 | 359篇 |
2003年 | 316篇 |
2002年 | 255篇 |
2001年 | 253篇 |
2000年 | 233篇 |
1999年 | 209篇 |
1998年 | 192篇 |
1997年 | 130篇 |
1996年 | 105篇 |
1995年 | 115篇 |
1994年 | 67篇 |
1993年 | 48篇 |
1992年 | 50篇 |
1991年 | 42篇 |
1990年 | 43篇 |
1989年 | 32篇 |
1988年 | 33篇 |
1987年 | 30篇 |
1986年 | 17篇 |
1985年 | 18篇 |
1984年 | 18篇 |
1983年 | 6篇 |
1982年 | 12篇 |
1981年 | 15篇 |
1980年 | 10篇 |
1979年 | 8篇 |
1978年 | 15篇 |
1977年 | 6篇 |
1976年 | 3篇 |
1971年 | 2篇 |
排序方式: 共有10000条查询结果,搜索用时 1 毫秒
1.
《Journal of pediatric surgery》2023,58(6):1213-1218
IntroductionEndoscopic surveillance guidelines for patients with repaired esophageal atresia (EA) rely primarily on expert opinion. Prior to embarking on a prospective EA surveillance registry, we sought to understand EA surveillance practices within the Eastern Pediatric Surgery Network (EPSN).MethodsAn anonymous, 23-question Qualtrics survey was emailed to 181 physicians (surgeons and gastroenterologists) at 19 member institutions. Likert scale questions gauged agreement with international EA surveillance guideline-derived statements. Multiple-choice questions assessed individual and institutional practices.ResultsThe response rate was 77%. Most respondents (80%) strongly agree or agree that EA surveillance endoscopy should follow a set schedule, while only 36% claimed to perform routine upper GI endoscopy regardless of symptoms. Many institutions (77%) have an aerodigestive clinic, even if some lack a multi-disciplinary EA team. Most physicians (72%) expressed strong interest in helping develop evidence-based guidelines.ConclusionsOur survey reveals physician agreement with current guidelines but weak adherence. Surveillance methods vary greatly, underscoring the lack of evidence-based data to guide EA care. Aerodigestive clinics may help implement surveillance schedules. Respondents support evidence-based protocols, which bodes well for care standardization. Results will inform the first multi-institutional EA databases in the United States (US), which will be essential for evidence-based care.Level of EvidenceThis is a prognosis study with level 4 evidence. 相似文献
2.
目的通过观察二甲双胍对糖尿病合并食管癌患者放疗效果,为糖尿病合并食管癌患者的治疗提供依据。方法选取2016年-2018年在该院确诊的糖尿病合并食管癌并口服二甲双胍降糖治疗的患者51例为观察组,同期诊断糖尿病合并食管癌并皮下注射胰岛素治疗的患者50例为对照组,所有的患者均实施内镜切除联合局部放疗治疗。治疗结束后随访1个月,根据RECIST标准对治疗效果进行评价两组患者的近期疗效。结果观察组患者近期疗效明显优于对照组(P<0.05)。结论二甲双胍可以提高食管癌患者的放疗效果。 相似文献
3.
4.
5.
食管癌放疗中二次模拟定位临床探讨 总被引:1,自引:0,他引:1
袁晔 《江苏大学学报(医学版)》2002,12(2):133-134
目的:探讨食管癌放疗中间再次定位的必要性和重要性。方法:我院放疗科自1998年10月-2001年3月对356例食管癌患者行单纯放疗或放疗加化疗,356例患者照射全过程都进行二次模拟定位(第一次模拟定位后照射30-40GY/15-20次后进行第2次模拟定位)。比较分析前后二次模拟定位靶中心移位的情况。结果;靶中心移位<0.5cm为157例,移位0.5-1.0cm为130例,移位>1.0cm为69例。全部靶中心移位达55.90%。食管肿瘤长度<5cm靶中心移位27例,5-8cm移位117例,病变长度>8cm移位55例,P<0.05;食管肿瘤发生于颈段,上胸段靶中心移位25例,而中、下段食管移位174例,P<0.01。结论:食管肿瘤外照射达到一定剂量时,靶中心会出现不同程度的移位,肿瘤长度越长靶中心移位会更明显, 肿瘤位置越小,移位亦显著。因此,我们对食管癌患者放疗全过程必需进行2到3次定位,这样才能保证靶中心的精确度,以达到预期治疗目的。 相似文献
6.
Burkhard H. A. von Rahden Brigitte Stigler Wolfgang Weiß Hubert J. Stein 《Journal of gastrointestinal surgery》2007,11(7):945-947
Management of upper gastrointestinal bleeding because of erosion of vessels by esophageal cancer may be challenging. We present
herein the angiographic images of a 49-year-old patient who was admitted with massive bleeding from a tumor-eroded inferior
thyroid artery. Attempts to control the bleeding by means of flexible endoscopy and insertion of a Sengstaken–Blakemore tube
had failed. The diagnosis was impressively demonstrated by multislice computed tomography with intravenous contrast in the
arterial phase and multiplanar reconstructions (computed tomography angiography) and by digital subtraction angiography. The
bleeding was successfully treated with superselective catheterization and coiling of the eroded vessel. 相似文献
7.
Robotic-assisted heller myotomy versus laparoscopic heller myotomy for the treatment of esophageal achalasia: multicenter study 总被引:3,自引:0,他引:3
Santiago Horgan M.D. Carlos Galvani M.D. Maria V. Gorodner M.D. Pablo Omelanczuck M.D. Fernando Elli M.D. Federico Moser M.D. Luis Durand M.D. Miguel Caracoche M.D. Jorge Nefa M.D. Sergio Bustos M.D. Phillip Donahue M.D. Pedro Ferraina M.D. 《Journal of gastrointestinal surgery》2005,9(8):1020-1030
Laparoscopic Heller myotomy (LHM) has become the standard treatment option for achalasia. The incidence of esophageal perforation
reported is about 5%–10%. Robotically assisted Heller myotomy (RAHM) is emerging as a safe alternative to LHM. Data comparing
the two approaches are scant. The aim of this study was to compare RAHM with LHM in terms of efficacy and safety for treatment
of achalasia. A total of 121 patients underwent surgical treatment of achalasia at three institutions. A retrospective review
of prospectively collected perioperative data was performed. Patients were divided into two groups: group A (RAHM), 59 patients,
and group B (LHM), 62 patients. All the operations were completed using minimally invasive techniques. There were 63 women
and 58 men, with a mean age of 45 ±19 years (14–82 years). Fifty-one percent of patients in group A and 95% of patients in
group B reported weight loss. Duration of symptoms was equal for both groups. Dysphagia was the main complaint in both groups
(P = NS). There was no difference in preoperative endoscopic treatment in both groups (44% versus 27%, P = NS). Operative
time was significantly shorter for LHM in the first half of the experience (141 ± 49 versus 122 ± 44 minutes, P < .05). However,
in the last 30 cases there was no difference in operative time between the groups (P = NS). Intraoperative complications (esophageal
perforation) were more frequent in group B (16% versus 0%). The incidence of postoperative heartburn did not differ by group.
There were no deaths. At 18 and 22 months, 92% and 90% of patients had relief of their dysphagia. This study suggests that
RAHM is safer than LHM, because it decreases the incidence of esophageal perforation to 0%, even in patients who had previous
treatment. At short-term follow-up, relief of dysphagia was equally achieved in both groups.
Presented at the Forty-Sixth Annual Meeting of The Society for Surgery of the Alimentary Tract, Chicago, Illinois, May 14–18,
2005 (oral presentation).
This study was supported in part by a grant provided by Intuitive Surgical, Inc. and Ethicon Endo-Surgery, Inc. 相似文献
8.
同步放化疗治疗中晚期食管癌60例 总被引:1,自引:0,他引:1
目的 观察对中晚期食管癌患者同步放化疗,疗效及毒副作用.方法 中晚期食管癌120例,随机分放化疗组60例(简称放化组)和单纯放疗组60例(简称单放组).放疗采用常规分割,DT40 Gy后缩小照射野,避开脊髓斜野照射,加量DT20~30 Gy,6~7周完成.放化组放疗1、4周后应用顺铂(DDP)20 mg/d、亚叶酸钙(CF)0.1 g/d,CF静脉滴注1/2量时5-氟尿嘧啶(5-Fu)500 mg/d静脉滴注,连续5 d为1个周期,化疗当天进行放疗.结果 放化组与单放组1、2、3年生存率分别为67%、46%、34%和52%、38%、24%;放射性肺炎分别为14例和12例;外周血细胞下降分别为26例和17例;胃肠道反应分别为25例和9例;死亡分别为38例和48例.两组治疗效果比较差异有统计学意义(P<0.05).结论 放疗同步PLF方案化疗治疗中晚期食管癌生存率高,毒副作用及不良反应低. 相似文献
9.
10.